首页|白藜芦醇通过核因子E2相关因子2/NAD(P)H:醌氧化还原酶1信号通路调控铁死亡的机制

白藜芦醇通过核因子E2相关因子2/NAD(P)H:醌氧化还原酶1信号通路调控铁死亡的机制

扫码查看
目的 探讨白藜芦醇(RES)通过激活核因子E2相关因子2(Nrf2)/NAD(P)H:醌氧化还原酶1(NQO1)信号通路在调控小鼠海马神经元HT22细胞铁死亡过程中的保护机制。方法 采用Erastin诱导HT22细胞模型模拟铁死亡,设置对照组、Erastin组、40、80 µmol/L RES处理组,以及Erastin+RES+ML385组。通过细胞计数试剂盒(CCK-8)检测细胞活力,流式细胞术和原位缺口末端标记法(TUNEL)法评估凋亡,试剂盒测定细胞内活性铁和活性氧(ROS)含量,荧光定量聚合酶链式反应(qPCR)和蛋白质印迹法(Western blot)分析Nrf2/NQO1信号通路。组间差异通过ANOVA和Tukey's post hoc测试确定。结果 0。6 μmol/L的Erastin组细胞活力显著低于40 µmol/L的RES组(51。00±2。90 比 68。12±2。24,t=2。902,P<0。05);RES 显著降低细胞凋亡率,80 µmol/L RES 处理的 HT22 细胞凋亡率显著低于 Erastin 组(6。12±0。93 比 18。21±2。05,t=3。858,P<0。05),效果最佳。80 µmol/L的RES组细胞内活性铁和ROS含量显著低于Erastin组(活性铁:43。14±3。13比65。11±4。07,t=3。821,P<0。05;ROS:8。04±0。83 比 25。02±1。57,t=5。852,P<0。05)。RES 预处理后Nrf2、NQO1和HO-1 mRNA及蛋白表达显著高于Erastin组(NQO1 mRNA:0。32±0。04比1。01±0。07,t=3。928,P<0。05;Nrf2 mRNA:0。25±0。03 比 1。04±0。06,t=3。785,P<0。05;HO-1 mRNA:0。26±0。05 比 1。02±0。08,t=3。957,P<0。05;NQO1 蛋白:0。96±0。04 比 0。45±0。07,t=3。792,P<0。05;Nrf2 蛋白:0。91±0。07 比 0。32±0。05,t=3。957,P<0。05;HO-1 蛋白:1。21±0。04比 0。25±0。03,t=4。535,P<0。05),而 ML385 逆转了 RES 的保护效果,导致 RES+Erastin+ML385组的 NQO1、Nrf2、HO-1 蛋白表达显著少于 RES+Erastin 组(NQO1:0。67±0。05 比 0。92±0。08,t=4。276,P<0。05;Nrf2:0。71±0。05 比 0。94±0。07,t=4。121,P<0。05;HO-1:0。64±0。04 比 1。16±0。04,t=3。978,P<0。05)。结论 RES可能通过激活Nrf2/NQO1信号通路,从而抑制Erastin诱导的神经元HT22细胞铁死亡。
The mechanism of resveratrol regulating iron death through nuclear factor erythroid 2-related factor 2/NAD(P)H:quinone oxidoreductase 1 signaling pathway
Objective To investigate the potential mechanism of resveratrol regulating iron death in HT22 cells of mouse hippocampal neurons by quantitative polymerase chain reaction(qPCR)and Western blotting.Differences between groups were determined by ANOVA and Tukey's post hoc tests.Methods HT22 cell ferroptosis model was induced by Erastin.The groups of control,Erastin,40 and 80 µmol/L RES,and Erastin+RES+ML385 were set up.Cell viability was tested by cell counting kit-8(CCK-8)assay,apoptosis was detected by flow cytometry and terminal-deoxynucleotidyl transferase media-ted nick end labeling(TUNEL),intracellular iron and ROS determined by kits,and Nrf2/NQO1 detected by quantitative polymerase chain reaction(qPCR)and Western blotting.Differences between groups were determined by ANOVA and Tukey's post hoc tests.Results The cell viability of 0.6 µmol/L Erastin group was significantly lower than that of 40μmol/L RES group(51.00±2.90 vs.68.12±2.24,t=2.902,P<0.05).The apoptosis rate of HT22 cells treated with 80μmol/L RES was significantly lower than that of Erastin group(6.12±0.93 vs.18.21±2.05,t=3.858,P<0.05).The contents of intra cellular active iron and ROS in 80 µmol/L RES group were significantly lower than those in Erastin group(active iron:43.14±3.13 vs.65.11±4.07,t=3.821,P<0.05;ROS:8.04±0.83 vs.25.02±1.57,t=5.852,P<0.05).The mRNA and protein expressions of Nrf2,NQO1 and HO-1 after RES pre-treatment were significantly higher than those in Erastin group(NQO1 mRNA:0.32±0.04 vs.1.01±0.07,t=3.928,P<0.05;Nrf2 mRNA:0.25±0.03 vs.1.04±0.06,t=3.785,P<0.05;HO-1 mR-NA:0.26±0.05 vs.1.02±0.08,t=3.957,P<0.05;NQO1 protein:0.96±0.04 vs.0.45±0.07,t=3.792,P<0.05;Nrf2 protein:0.91±0.07 vs.0.32±0.05,t=3.957,P<0.05;HO-1 protein:1.21±0.04 vs.0.25±0.03,t=4.535,P<0.05),while ML385 reversed the protective effect of RES,resulting in significantly lower expression of NQO1,Nrf2 and HO-1 protein in RES+Erastin+ML385 group than in RES+Erastin group(NQO1:0.67±0.05 vs.0.92±0.08,t=4.276,P<0.05;Nrf2:0.71±0.05 vs.0.94±0.07,t=4.121,P<0.05;HO-1:0.64±0.04 vs.1.16±0.04,t=3.978,P<0.05).Conclusion Resveratrol may inhibit Erastin-induced iron death in HT22 cells by activating Nrf2/NQO1 pathway.

ResveratrolNuclear factor erythroid 2NeuronsFerroptosis

张林、郭田田、王纵、李力、杨扬

展开 >

驻马店市中心医院血管神经外科,驻马店 463000

驻马店市中心医院感染管理科,驻马店 463000

驻马店市中心医院神经外一科,驻马店 463000

驻马店市中心医院科研管理科,驻马店 463000

展开 >

白藜芦醇 核因子E2相关因子2 神经元 铁死亡

河南医学科技攻关计划联合共建立项项目

LHGJ20200701

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(8)